Coherus Oncology, Inc.
CHRS
$1.20
$0.065.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 46.17% | -1.82% | -5.94% | -- | -- |
| Total Depreciation and Amortization | -2.16% | -1.67% | -7.25% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -396.33% | 369.03% | 128.97% | -- | -- |
| Change in Net Operating Assets | -38.16% | -244.93% | 274.03% | -- | -- |
| Cash from Operations | -7.26% | -193.60% | 57.45% | -- | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.34% | 1,180.16% | 95.78% | -- | -- |
| Cash from Investing | -3.34% | 1,180.16% | 95.78% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.62% | 565.72% | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 21.15% | 136.36% | 340.00% | -- | -- |
| Cash from Financing | -99.73% | 563.16% | 403,950.00% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -222.60% | 282.13% | 87.26% | -- | -- |